CNS Pharmaceuticals Inc. (CNSP) stock soars during pre-market. What’s driving it high?
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) stock gained by 2.78% at last close while the CNSP stock price surged by 7.57% in the pre-market trading. CNS Pharmaceuticals is a clinical-stage pharmaceutical business working on anti-cancer medication candidates for the cure of brain and central nervous system tumors, both primary and metastatic. Berubicin, CNSP’s primary medication candidate, […]
CNS Pharmaceuticals Inc. (CNSP) stock surges during current market trading. Here’s to know why?
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) stock gains by 8.46% in the current market trading session. CNS Pharmaceuticals is a clinical-stage pharmaceutical business researching anti-cancer medication candidates for the cure of brain and central nervous system tumors, both primary and metastatic. >> 7 Top Picks for the Post-Pandemic Economy << What is happening? The US Food […]
